There was recently an interview with a good Australian healthcare investor (Platinum) where she mentions Imricor. I've put the link below (mentioned around the 20m mark) - the whole thing is worth a listen but the IMR snippet backs up a core part of the investment thesis in that the MRI modality is the innovation that electrophysicans have been waiting for for many years in this space. Over to the team to execute now and keep the market updated, but I trust them to do so and think this easily becomes a takeover target once approval for VT in Europe and hopefully the US comes through in N1Y or so. Do you own research obviously, all this is disclosed on their announcements, but I like this name given the asymmetric risk/reward skew and the win-win-win the product brings to the cardiac ablation space. It helps that it's being led by Steve Wedan who is an internationally renowned expert in this space.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)